JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

High incidence of symptomatic Meckel's diverticulum in patients less than fifty years of age: an indication for resection.

American Surgeon 2007 March
Meckel's diverticulum is a congenital diverticulum of the small intestine. Complications include perforation, inflammation, bleeding, obstruction, and volvulus. Resection of asymptomatic Meckel's diverticula [corrected] has been recommended; however, indications are not well defined. To delineate indications to resect asymptomatic Meckel's diverticulum, the charts of 16 men and 13 women, mean age 55.1 +/- 23 years, confirmed at surgery with Meckel's diverticula [corrected] were retrospectively reviewed. Two groups were identified: symptomatic resected (9); asymptomatic (20), which included resected (10) or not resected (10). The age ranges, male:female (M:F) ratios, the height:diameter ratios, heterotopic tissue, surgical management, and complications were recorded and compared. The average age for symptomatic resection was 34.9 +/- 23.2 years compared with 64.2 +/- 16.5 years for asymptomatic patients (P = 0.0006). Of patients under 50 years of age, 70 per cent (7/10) were symptomatic compared with 10 per cent (2/19) of those over 50 years of age. Overall, the M:F ratios between the groups were similar, and the average M:F ratio was 1.23:1. Surgical management of resected Meckel's diverticula [corrected] included 10 segmental resections and 10 diverticulectomies; one of each was laparoscopic. There were no differences in the complication rate, nor in outcomes between the groups. Heterotopic tissue was only identified in symptomatic patients, 33 per cent (3/9) versus 0 per cent (0/10) in resected asymptomatic patients. The height:diameter ratios were similar between the groups. Adult patients with symptomatic Meckel's diverticula [corrected] were more likely to be under the age of 50 and to have heterotrophic tissue. Resection of asymptomatic Meckel's diverticulum should be considered in patients under 50 years of age; patients over age 50 years of age will be less likely to benefit from prophylactic resection.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app